{
    "nctId": "NCT00742222",
    "briefTitle": "Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer",
    "officialTitle": "Electronic Xoft Intersociety Brachytherapy Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Carcinoma, Lumpectomy, Ductal Carcinoma in Situ",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 63,
    "primaryOutcomeMeasure": "The incidence of signs and symptoms of subcutaneous toxicities will be recorded at the following follow-up visits; six month, one year, two year, three year, four year, and five year.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient 50 years of age or older\n* Estrogen receptor positive\n* Tumor size \u2264 3cm\n* Tumor histology: invasive carcinoma or DCIS\n* Patient is node negative\n* Patient has negative surgical margins (NSABP definition, no tumor on ink) after final surgery\n* Life expectancy \\> 5 years\n\nExclusion Criteria:\n\n* Pregnancy or breast-feeding. (If appropriate, patient must use birth control during the registry.) The need for a pregnancy test is based on the physician's standard practice and will be performed according to the physician's standard of care.\n* Collagen Vascular Disease\n* Scleroderma\n* Systemic sclerosis\n* Active lupus\n* Infiltrating lobular histology\n* Previous ipsilateral radiation to the thorax or breast",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}